VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,130,092 | -1.9% | 42,011 | +9.8% | 0.20% | +1.5% |
| Q2 2023 | $1,152,031 | +8.8% | 38,261 | +16.8% | 0.20% | +4.2% |
| Q1 2023 | $1,059,131 | +29.0% | 32,750 | +14.3% | 0.19% | +24.2% |
| Q4 2022 | $820,819 | +23.1% | 28,650 | +3.5% | 0.15% | +15.9% |
| Q3 2022 | $667,000 | -9.4% | 27,685 | +3.0% | 0.13% | -5.0% |
| Q2 2022 | $736,000 | -28.4% | 26,885 | +0.2% | 0.14% | -16.8% |
| Q1 2022 | $1,028,000 | +2.3% | 26,825 | -8.2% | 0.17% | -0.6% |
| Q4 2021 | $1,005,000 | +21.7% | 29,225 | +4.3% | 0.17% | +19.1% |
| Q3 2021 | $826,000 | +3654.5% | 28,025 | +4278.9% | 0.14% | +3425.0% |
| Q2 2021 | $22,000 | +4.8% | 640 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | +2000.0% | 640 | +4166.7% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |